ONLINE DAT BENZODIAZEPINES PLUS 04499069190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2015-01-14 for ONLINE DAT BENZODIAZEPINES PLUS 04499069190 manufactured by Roche Diagnostics.

Event Text Entries

[5279150] The customer reported that they have received false positive results for two samples from the same patient tested for benzodiazepines plus (benz) on a p module analyzer. For the benz test, the customer uses a semi-quantitative application with a 200 ng/ml cutoff. The first sample initially resulted as 559 ng/ml and this value was reported outside of the laboratory as positive. The sample was sent to a confirmatory laboratory and repeated for confirmation using lc-ms/ms methodology. The lc-ms/ms confirmation results were negative for nordiazepam, oxazepam, temazepam, lorazepam, flurazepam metabolite, and alprazolam. The confirmation results were believed to be correct. The second sample was initially tested on (b)(6) 2014 and resulted as 485 ng/ml which was reported outside of the laboratory as positive. The confirmation results were believed to be correct. The sample was repeated by itself to verify if it still recovered positive and to rule out carry over from another sample or reagent. The repeat benz result was 351 ng/ml, which is considered positive. The sample was also retested at the confirmatory laboratory with an extended metabolite panel, resulting as negative for clonazepam. The patient was not adversely affected. The p module analyzer serial number was (b)(4). The customer declined a service visit. The patient is taking naltrexone medication and it was determined that naltrexone does not cross-react with the benz test. The customer has stated that they have multiple drugs of abuse test open channels on the analyzer in question. It was determined that there were no special washes in place for several of these tests, including: "etg", "xtc", "tca", "bups", "amp-c", "barbc", and "k2".
Patient Sequence No: 1, Text Type: D, B5


[12815685] It was unknown if the initial reporter sent report to the fda.
Patient Sequence No: 1, Text Type: N, H10


[12891220] As part of investigations, it was noted that the expected maximum concentrations of naltrexone main metabolite and sitagliptine are both slightly below a level that can render them candidates for an interference. But both in sum and taken together could exceed the critical threshold under certain circumstances, though this does not seem likely.
Patient Sequence No: 1, Text Type: N, H10


[13105124] For investigations, the combination naltrexone and sitagliptine was tested and a possible interference with the combination can be ruled out. The patient sample is not available for further investigation. It has been concluded that an unknown substance in the sample is interfering with the assay.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2015-00319
MDR Report Key4419151
Report Source05,06
Date Received2015-01-14
Date of Report2015-03-23
Date of Event2014-12-17
Date Mfgr Received2014-12-30
Date Added to Maude2015-01-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameONLINE DAT BENZODIAZEPINES PLUS
Generic NameENZYME IMMUNOASSAY, BENZODIAZIPINE
Product CodeJXM
Date Received2015-01-14
Model NumberNA
Catalog Number04499069190
Lot Number69390101
ID NumberNA
Device Expiration Date2015-10-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2015-01-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.